Samul Extract Protects Against the H2O2-induced Apoptosis of H9c2 Cardiomyoblasts Via Activation of Extracellular Regulated Kinases (Erk) 1/2
Overview
Authors
Affiliations
Samul extract, containing Radix Rehmanniae, Radix Angelicae Gigantis, Radix Paeoniae, and Rhizoma Cnidii, has been traditionally used for treatment of ischemic heart and brain damages in Oriental medicine. However, little is known about the mechanism by which Samul rescues cells from cytotoxic damage. This study was designed to investigate the protective mechanisms of Samul on H(2)O(2)-induced death of H9c2 cells. Treatment with H(2)O(2) markedly decreased the viability of H9c2 cells in a dose- and time-dependent manner, which was significantly prevented by pre-treatment with Samul. The nature of death of H9c2 cells by H(2)O(2) was demonstrated by apoptotic features, including ladder-pattern fragmentation of genomic DNA and chromatin condensation, which were markedly abolished by pretreatment of Samul in H(2)O(2)-treated cells. We further demonstrated that MEK inhibitor, PD98059, dose-dependently attenuated the protective effects of Samul against H(2)O(2), whereas inhibitors of Jnk and p38 did not. Consistently, Samul induced the early phosphorylation of Erk, p44, in H(2)O(2)-treated cells. In addition, treatment with Samul also resulted in an increase of expression of anti-apotogenic Bcl2 protein, which was decreased by H(2)O(2). However, it inhibited the expression of apotogenic Bax protein in H(2)O(2)-treated cells. Taken together, these results suggest that the protective effects of Samul against oxidative damage may be achieved via activation of MAP kinase, Erk as well as Bcl2 family proteins.
Harishkumar R, Manjari M, Rose C, Selvaraj C Mol Biol Rep. 2019; 47(2):1117-1128.
PMID: 31823124 DOI: 10.1007/s11033-019-05208-5.
Chen Y, Tsai Y, Lee C, Lee C, Chen C, Liu C PLoS One. 2014; 9(9):e106812.
PMID: 25268131 PMC: 4182104. DOI: 10.1371/journal.pone.0106812.
Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.
Jaiman S, Sharma A, Singh K, Khanna D Eur J Clin Pharmacol. 2013; 69(11):1863-74.
PMID: 23929259 DOI: 10.1007/s00228-013-1568-7.
Lee M, Chen H, Tzang B, Lin C, Wang C, Liu J Evid Based Complement Alternat Med. 2010; 2011.
PMID: 20953436 PMC: 2952314. DOI: 10.1155/2011/578060.
Wang B, Shravah J, Luo H, Raedschelders K, Chen D, Ansley D Biochem Biophys Res Commun. 2009; 389(1):105-11.
PMID: 19703415 PMC: 3631547. DOI: 10.1016/j.bbrc.2009.08.097.